High materiality8/10
Scribe Therapeutics initiated with a Buy at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
H.C. Wainwright initiates SCTX with Buy; target $60; price $28.44; priceChangeSinceSignal +7.38.
Target: $60
Posted price: $28.44
Analyst firm: H.C. Wainwright
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.